Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

458
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
458
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

878
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
878

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.

Brain : a journal of neurology·2021
Same author

The contribution of behavioral features to caregiver burden in FTLD spectrum disorders.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2021
Same author

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding <sup>18</sup>F-FDG-PET.

Brain communications·2021
Same author

The temporal onset of the core features in dementia with Lewy bodies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2021
Same author

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder.

Journal of Parkinson's disease·2021
Same author

Regional Brain Stiffness Analysis of Dementia with Lewy Bodies.

Journal of magnetic resonance imaging : JMRI·2021
Same journal

Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy.

Focus (American Psychiatric Publishing)·2026
Same journal

Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes.

Focus (American Psychiatric Publishing)·2026
Same journal

Violence Risk Factors in Psychiatric Populations.

Focus (American Psychiatric Publishing)·2026
Same journal

Contextualizing Violence Risk Associated With Hallucinogens.

Focus (American Psychiatric Publishing)·2026
Same journal

Ethical and Legal Aspects of Forensic Psychiatry.

Focus (American Psychiatric Publishing)·2026
Same journal

From Fear to Framework: Toward Understanding of Violence and Mental Illness.

Focus (American Psychiatric Publishing)·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Studying Pre-formed Fibril Induced &#945;-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.1K

Lewy Body Dementias.

Zuzana Walker, Katherine L Possin, Bradley F Boeve

    Focus (American Psychiatric Publishing)
    |January 31, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This study investigated the impact of air pollution on cardiovascular health. Findings indicate a significant association between particulate matter exposure and increased risk of heart disease.

    More Related Videos

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    18.0K
    Technique for Intranasal Administration of &#945;-Synuclein Aggregates
    04:49

    Technique for Intranasal Administration of α-Synuclein Aggregates

    Published on: November 8, 2024

    915

    Related Experiment Videos

    Last Updated: Dec 29, 2025

    Studying Pre-formed Fibril Induced &#945;-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
    10:03

    Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

    Published on: August 16, 2020

    11.1K
    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    18.0K
    Technique for Intranasal Administration of &#945;-Synuclein Aggregates
    04:49

    Technique for Intranasal Administration of α-Synuclein Aggregates

    Published on: November 8, 2024

    915

    Area of Science:

    • Environmental health
    • Cardiovascular medicine
    • Epidemiology

    Background:

    • Air pollution is a growing global concern with significant public health implications.
    • Cardiovascular diseases remain a leading cause of mortality worldwide.
    • Understanding the link between environmental factors and heart health is crucial for preventative strategies.

    Purpose of the Study:

    • To examine the association between exposure to ambient air pollution and the incidence of cardiovascular events.
    • To quantify the risk of cardiovascular mortality attributable to specific air pollutants.

    Main Methods:

    • A large-scale cohort study design was employed, following a diverse population over an extended period.
    • Individual exposure levels to key air pollutants, including particulate matter (PM2.5) and nitrogen dioxide (NO2), were estimated.
    • Statistical models, such as Cox proportional hazards regression, were used to analyze the relationship between pollution exposure and cardiovascular outcomes.

    Main Results:

    • Increased exposure to fine particulate matter (PM2.5) was significantly associated with a higher risk of myocardial infarction and stroke.
    • A dose-response relationship was observed, with greater pollution exposure correlating with increased cardiovascular mortality.
    • Long-term exposure to air pollution demonstrated a cumulative detrimental effect on cardiovascular health.

    Conclusions:

    • Ambient air pollution, particularly fine particulate matter, poses a substantial risk to cardiovascular health.
    • Public health initiatives aimed at reducing air pollution levels are essential for mitigating the burden of cardiovascular diseases.
    • Further research is warranted to explore the specific biological mechanisms underlying pollution-induced cardiovascular damage.